
This episode discusses health trends, political candidates, and recent IPOs. Guests include Chamath Palihapitiya, David Sacks, and Jason Calacanis.
The conversation begins with health topics, including cold plunges and saunas, as Chamath shares his recent weight loss and energy levels. They discuss the benefits of cold exposure and the importance of tracking health metrics.
Political discussions focus on candidates like Vivek Ramaswamy and Robert F. Kennedy Jr. The guests analyze their potential impact on the upcoming elections, with Chamath expressing interest in Vivek's policies.
The episode transitions to the IPO market, highlighting recent public offerings like Instacart and Clavio. The guests critique the structure of these IPOs and discuss market dynamics affecting valuations.
Finally, the episode features a science corner discussing breakthroughs in autoimmune disease treatment, emphasizing a new approach that could revolutionize how these conditions are managed.
Health trends, political candidates, and IPO market insights discussed by Chamath, Sacks, and Calacanis.

I think avoiding World War III is the central issue of the campaign.E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more
This is the priority and I came away from it so intellectually stimulated.E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more
Most people are not willing to do the work.E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more
Investors do not like existential risk; it’s a smart move to mitigate it.E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more
I think now you got to be Q1 of 26.E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more
This is like friendly fire, right?E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more